Go Pro

Baxter International (BAX) Stock Price, News & Analysis

Baxter International logo
$23.02 -0.51 (-2.16%)
Closing price 09/17/2026 03:59 PM Eastern
Extended Trading
$22.87 -0.15 (-0.66%)
As of 09/17/2026 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Baxter International Stock (NYSE:BAX)

Advanced

Key Stats

Today's Range
$22.98
$23.74
50-Day Range
$21.71
$28.32
52-Week Range
$15.73
$30.00
Volume
6.61 million shs
Average Volume
4.75 million shs
Market Capitalization
$11.90 billion
P/E Ratio
N/A
Dividend Yield
0.17%
Price Target
$22.45
Consensus Rating
Hold

Company Overview

Baxter International Inc. is a global healthcare company that develops and supplies medical products and technologies used in hospitals, outpatient facilities, physician offices and other care settings. Its offerings include intravenous therapy products and infusion systems, injectable medications and drug-compounding technologies, surgical products, patient-monitoring systems, respiratory-care equipment, and products used in hospital beds and connected-care environments.

The company serves healthcare providers and patients in numerous countries, with operations and customers across North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. Baxter’s products are designed to support medication delivery, fluid management, clinical nutrition, surgery, patient monitoring and other essential aspects of care.

Founded in 1931, Baxter has expanded through the development and acquisition of medical technologies and healthcare businesses. The company was historically also a major provider of products for kidney-care and renal-therapy services, but it announced the sale of its Kidney Care business, now known as Vantive, as part of a strategy to focus on its core hospital and medical-product operations.

AI Generated. May Contain Errors.

Baxter International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

BAX MarketRank™: 

Baxter International scored higher than 28% of companies evaluated by MarketBeat, and ranked 792nd out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Baxter International has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 2 buy ratings, 9 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Baxter International is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Baxter International has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Baxter International's stock forecast and price target.
  • Earnings Growth

    Earnings for Baxter International are expected to decrease by -1.47% in the coming year, from $2.04 to $2.01 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Baxter International is -11.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Baxter International is -11.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Baxter International has a PEG Ratio of 3.55. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Baxter International has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Baxter International's valuation and earnings.
  • Percentage of Shares Shorted

    4.51% of the float of Baxter International has been sold short.
  • Short Interest Ratio / Days to Cover

    Baxter International has a short interest ratio ("days to cover") of 4.99.
  • Change versus previous month

    Short interest in Baxter International has recently decreased by 2.60%, indicating that investor sentiment is improving.
  • Dividend Yield

    Baxter International has a dividend yield of 0.17%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Baxter International does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Baxter International will have a dividend payout ratio of 1.99% next year. This indicates that Baxter International will be able to sustain or increase its dividend.

  • Read more about Baxter International's dividend.
  • News Sentiment

    Baxter International has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Baxter International this week, compared to 10 articles on an average week.
  • Search Interest

    Only 7 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -68% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Baxter International insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.17% of the stock of Baxter International is held by insiders.

  • Percentage Held by Institutions

    90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Baxter International's insider trading history.
Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BAX Stock News Headlines

Zacks Research Has Positive Estimate for BAX Q4 Earnings
Zacks Research Issues Optimistic Estimate for BAX Earnings
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.tc pixel
Baxter Appoints John Rogers Chief Financial Officer
See More Headlines

BAX Stock Analysis - Frequently Asked Questions

Baxter International's stock was trading at $19.12 on January 1st, 2026. Since then, BAX stock has increased by 20.4% and is now trading at $23.0210.

Baxter International Inc. (NYSE:BAX) issued its earnings results on Thursday, July, 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.19. The business's quarterly revenue was up 5.3% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Baxter International: Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and others.

Top institutional shareholders of Baxter International include BlackRock Inc. (15.83%), Pzena Investment Management LLC (12.63%), Equity Investment Corp (1.33%) and Bank of America Corp DE (1.21%).
View institutional ownership trends
.

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), ExxonMobil (XOM), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Intel (INTC).

Company Calendar

Record date for 7/1 Dividend
5/29/2026
Ex-Dividend for 7/1 Dividend
5/29/2026
Dividend Payable
7/01/2026
Last Earnings
7/30/2026
Record date for 10/1 Dividend
8/28/2026
Ex-Dividend for 10/1 Dividend
8/28/2026
Today
9/17/2026
Dividend Payable
10/01/2026
Next Earnings (Estimated)
10/29/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSE:BAX
CIK
10456
Employees
37,500
Year Founded
1931

Price Target and Rating

High Price Target
$28.00
Low Price Target
$15.00
Potential Upside/Downside
-2.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
11.28
P/E Growth
3.55
Net Income
-$957 million
Net Margins
-9.27%
Pretax Margin
-4.21%
Return on Equity
16.57%
Return on Assets
5.24%

Debt

Debt-to-Equity Ratio
1.39
Current Ratio
1.95
Quick Ratio
1.32

Sales & Book Value

Annual Sales
$11.24 billion
Price / Sales
1.06
Cash Flow
$5.56 per share
Price / Cash Flow
4.14
Book Value
$11.87 per share
Price / Book
1.94

Miscellaneous

Outstanding Shares
517,000,000
Free Float
516,117,000
Market Cap
$11.90 billion
Optionable
Optionable
Beta
0.60

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NYSE:BAX) was last updated on 9/18/2026 by MarketBeat.com Staff.
From Our Partners